Krystal Biotech (KRYS)
NASDAQ:KRYS
Holding KRYS?
Track your performance easily

Krystal Biotech (KRYS) Financial Statements

437 Followers

Krystal Biotech Financial Overview

Krystal Biotech's market cap is currently ―. The company's EPS TTM is $3.653; its P/E ratio is 50.02; Krystal Biotech is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $1.02. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 70.28M$ 45.25M$ 42.14M$ 8.60M-
Gross Profit$ 70.28M$ 45.25M$ 39.27M$ 8.60M-
EBIT$ 16.05M$ -4.26M$ 113.26M$ 74.50M$ -38.05M
EBITDA$ 18.07M$ -2.66M$ 115.70M$ 75.32M$ -38.05M
Net Income Common Stockholders$ 14.10M$ 932.00K$ 8.69M$ 81.24M$ -33.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 559.61M$ 538.26M$ 532.18M$ 562.07M$ 477.52M
Total Assets$ 917.66M$ 853.30M$ 818.36M$ 790.35M$ 684.03M
Total Debt$ 7.69M$ 7.89M$ 8.09M$ 8.32M$ 8.54M
Net Debt$ -551.92M$ -530.36M$ -524.08M$ -553.75M$ -468.97M
Total Liabilities$ 78.77M$ 54.05M$ 39.71M$ 34.40M$ 30.91M
Stockholders Equity$ 838.92M$ 799.24M$ 778.64M$ 755.95M$ 653.08M
Cash Flow-
Free Cash Flow$ -5.30M$ 14.63M$ -9.08M$ 76.99M$ -33.21M
Operating Cash Flow$ -4.17M$ 15.89M$ -7.23M$ -21.23M$ -33.21M
Investing Cash Flow$ -19.35M$ -25.98M$ -10.16M$ 105.19M-
Financing Cash Flow$ 10.64M$ 10.58M$ 2.62M$ 13.39M-
Currency in USD

Krystal Biotech Earnings and Revenue History

Krystal Biotech Debt to Assets

Krystal Biotech Cash Flow

Krystal Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis